- Home
- RWT vs GERN Comparison
RWT vs GERN Comparison
Compare RWT & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RWT
- GERN
- Stock Information
- Founded
- RWT 1994
- GERN 1990
- Country
- RWT United States
- GERN United States
- Employees
- RWT N/A
- GERN N/A
- Industry
- RWT Real Estate Investment Trusts
- GERN Biotechnology: Pharmaceutical Preparations
- Sector
- RWT Real Estate
- GERN Health Care
- Exchange
- RWT Nasdaq
- GERN Nasdaq
- Market Cap
- RWT 756.1M
- GERN 823.0M
- IPO Year
- RWT 1995
- GERN 1996
- Fundamental
- Price
- RWT $6.23
- GERN $1.27
- Analyst Decision
- RWT Buy
- GERN Buy
- Analyst Count
- RWT 9
- GERN 8
- Target Price
- RWT $7.36
- GERN $3.71
- AVG Volume (30 Days)
- RWT 886.5K
- GERN 6.4M
- Earning Date
- RWT 10-29-2025
- GERN 11-06-2025
- Dividend Yield
- RWT 11.58%
- GERN N/A
- EPS Growth
- RWT N/A
- GERN N/A
- EPS
- RWT N/A
- GERN N/A
- Revenue
- RWT $136,246,000.00
- GERN $164,447,000.00
- Revenue This Year
- RWT N/A
- GERN $175.15
- Revenue Next Year
- RWT $26.89
- GERN $56.61
- P/E Ratio
- RWT N/A
- GERN N/A
- Revenue Growth
- RWT N/A
- GERN 11877.20
- 52 Week Low
- RWT $4.68
- GERN $1.09
- 52 Week High
- RWT $8.15
- GERN $4.83
- Technical
- Relative Strength Index (RSI)
- RWT 57.25
- GERN 40.76
- Support Level
- RWT $6.13
- GERN $1.27
- Resistance Level
- RWT $6.28
- GERN $1.52
- Average True Range (ATR)
- RWT 0.12
- GERN 0.06
- MACD
- RWT 0.01
- GERN -0.02
- Stochastic Oscillator
- RWT 53.77
- GERN 0.00
About RWT Redwood Trust Inc.
Redwood Trust Inc is a real estate investment trust focused on different areas of housing credit. The company operates in three segments: Sequoia Mortgage Banking includes mortgage loan conduit that acquires residential consumer loans from third-party originators for sale to whole loan buyers and securitization; CoreVest Mortgage Banking segment includes consists of a platform that originates residential investor loans for securitization, sale, or transfer into Redwood Investments portfolio; and Redwood Investments segment consists of organic investments sourced through mortgage banking operations, including securities retained from Sequoia and CoreVest securitization activities. It derives maximum revenue from Redwood Investments segment.
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.